Publications by authors named "Sherry Li"

Claim this Profile
A
A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Brensocatib in Adults with Cystic Fibrosis.
Michael W Konstan, James J Tolle, Emily DiMango, Patrick A Flume, Helen Usansky, Sherry Li

Clin Pharmacokinet· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatment.
Sichen Yuan, Xicheng Yang, Alexa M Bremmer, Yixin Wang, Sherry Li

Proc Natl Acad Sci U S A· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glaucoma detection and staging from visual field images using machine learning techniques.
Nahida Akter, Jack Gordon, Sherry Li, Mikki Poon, Stuart Perry

PLoS One· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microglia Mediate Contact-Independent Neuronal Network Remodeling via Secreted Neuraminidase-3 Associated with Extracellular Vesicles.
Corleone S Delaveris, Catherine L Wang, Nicholas M Riley, Sherry Li, Rishikesh U Kulkarni

ACS Cent Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microglia mediate contact-independent neuronal pruning via secreted Neuraminidase-3 associated with extracellular vesicles.
Corleone S Delaveris, Catherine L Wang, Nicholas M Riley, Sherry Li, Rishikesh U Kulkarni

bioRxiv· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenic and immunomodulatory biomarkers in axitinib-treated patients with advanced renal cell carcinoma.
Danielle A Murphy, Brian I Rini, Bernard Escudier, Robert J Motzer, Panpan Wang, Sherry Li, J Andrew Williams

Future Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration.
Alexander Drilon, Jeffrey W Clark, Jared Weiss, Sai-Hong Ignatius Ou, D Ross Camidge, Liza C Villaruz, Sherry Li

Nat Med· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial.
Alice T Shaw, Benjamin J Solomon, Rita Chiari, Gregory J Riely, Benjamin Besse, Chia-Chi Lin, Sherry Li

Lancet Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer.
Alice T Shaw, Benjamin J Solomon, Benjamin Besse, Todd M Bauer, Chia-Chi Lin, Sherry Li, Enriqueta Felip

J Clin Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomic analyses of sunitinib in patients with pancreatic neuroendocrine tumors.
Nicola Fazio, Jean-Francois Martini, Adina E Croitoru, Michael Schenker, Sherry Li

Future Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis.
Daniel J George, Jean-Francois Martini, Michael Staehler, Robert J Motzer, Ahmed Magheli, Sherry Li

Clin Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study.
Daniel J George, Jean-François Martini, Michael Staehler, Robert J Motzer, Ahmed Magheli, Sherry Li

Clin Cancer Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of PF-04449913, an oral hedgehog inhibitor, in patients with advanced solid tumors.
Andrew J Wagner, Wells A Messersmith, M Naveed Shaik, Sherry Li, Xianxian Zheng

Clin Cancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II open-label study of sunitinib in patients with advanced breast cancer.
Denise A Yardley, E Claire Dees, Stephen D Myers, Sherry Li, Paul Healey, Jolanda Paolini

Breast Cancer Res Treat· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Speciation of vanadium in oilsand coke and bacterial culture by high performance liquid chromatography inductively coupled plasma mass spectrometry.
X Sherry Li, Susan Glasauer, X Chris Le

Anal Chim Acta· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated levels and distinct patterns of expression of A-type cyclins and their associated cyclin-dependent kinases in male germ cell tumors.
Ching Liao, Sherry Q Li, XiangYuan Wang, Samantha Muhlrad, Anders Bjartell

Int J Cancer· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of hTERT mRNA in colonic brush specimens as an adjunct to cytopathologic diagnosis of colonic adenocarcinoma.
Sherry Q Li, Zong-Mei Sheng, YuJing Baili, Yener S Erozan, Timothy J O'Leary

Acta Cytol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis